Pacific Biosciences
PACB
#6557
Rank
C$0.99 B
Marketcap
C$3.30
Share price
-5.16%
Change (1 day)
18.93%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of September 2025 : C$0.41 Billion

According to Pacific Biosciences 's latest financial reports the company has C$0.41 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.55 B-33.19%
2023-12-31C$0.83 B-20.09%
2022-12-31C$1.04 B-21.26%
2021-12-31C$1.33 B227.43%
2020-12-31C$0.40 B533.92%
2019-12-31C$64.12 M-54.01%
2018-12-31C$0.13 B76.39%
2017-12-31C$79.04 M-18.28%
2016-12-31C$96.72 M-15.24%
2015-12-31C$0.11 B-2.97%
2014-12-31C$0.11 B-1.81%
2013-12-31C$0.11 B19.77%
2012-12-31C$0.10 B-44.58%
2011-12-31C$0.18 B-36.35%
2010-12-31C$0.28 B190.61%
2009-12-31C$97.57 M-24.33%
2008-12-31C$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Illumina
ILMN
C$1.76 B 327.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
C$0.13 B-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$18.66 B 4,423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$4.89 B 1,087.33%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
C$3.40 B 724.08%๐Ÿ‡บ๐Ÿ‡ธ USA